Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
RNA (New York, N.Y.)
|
March 28, 2008
miR-148 targets human DNMT3b protein coding region
Anja M Duursma, Martijn Kedde, Mariette Schrier, et al.
Genome Biology
|
July 4, 2012
E2F mediates enhanced alternative polyadenylation in proliferation
Ran Elkon, Jarno Drost, Gijs van Haaften, et al.
Future Oncology (London, England)
|
April 27, 2019
A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX)
Axel Bex, Johan V van Thienen, Mariette Schrier, et al.
The EMBO Journal
|
July 14, 2007
Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation
Carlos le Sage, Remco Nagel, David A Egan, et al.
Human Molecular Genetics
|
April 18, 2003
The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome
Rob Willemsen, Marianne Hoogeveen-Westerveld, Surya Reis, et al.
Nature Cell Biology
|
January 15, 2008
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Qihong Huang, Kiranmai Gumireddy, Mariette Schrier, et al.
Advances in Experimental Medicine and Biology
|
August 19, 2007
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
P Mathijs Voorhoeve, Carlos le Sage, Mariette Schrier, et al.
Cell
|
March 28, 2006
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
P Mathijs Voorhoeve, Carlos le Sage, Mariette Schrier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2026
PI3K inhibition in combination with tamoxifen in patients with metastatic HR+/HER2- breast cancer: clinical and circulating tumor DNA results
Rosie A B Voorthuis, Mafalda Oliveira, Annelot G J van Rossum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients
Richard D Baird, Annelot G J van Rossum, Mafalda Oliveira, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
RNA (New York, N.Y.)
|
March 28, 2008
miR-148 targets human DNMT3b protein coding region
Anja M Duursma, Martijn Kedde, Mariette Schrier, et al.
Genome Biology
|
July 4, 2012
E2F mediates enhanced alternative polyadenylation in proliferation
Ran Elkon, Jarno Drost, Gijs van Haaften, et al.
Future Oncology (London, England)
|
April 27, 2019
A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX)
Axel Bex, Johan V van Thienen, Mariette Schrier, et al.
The EMBO Journal
|
July 14, 2007
Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation
Carlos le Sage, Remco Nagel, David A Egan, et al.
Human Molecular Genetics
|
April 18, 2003
The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome
Rob Willemsen, Marianne Hoogeveen-Westerveld, Surya Reis, et al.
Nature Cell Biology
|
January 15, 2008
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Qihong Huang, Kiranmai Gumireddy, Mariette Schrier, et al.
Advances in Experimental Medicine and Biology
|
August 19, 2007
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
P Mathijs Voorhoeve, Carlos le Sage, Mariette Schrier, et al.
Cell
|
March 28, 2006
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
P Mathijs Voorhoeve, Carlos le Sage, Mariette Schrier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2026
PI3K inhibition in combination with tamoxifen in patients with metastatic HR+/HER2- breast cancer: clinical and circulating tumor DNA results
Rosie A B Voorthuis, Mafalda Oliveira, Annelot G J van Rossum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients
Richard D Baird, Annelot G J van Rossum, Mafalda Oliveira, et al.
Page
of 1